The Application of Multimodal Ultrasound Imaging in Carpal Tunnel Syndrome

The aim of this study is to explore the application value of multimodal ultrasound parameters in the diagnosis and treatment follow-up of Carpal Tunnel Syndrome.

Study Overview

Status

Not yet recruiting

Study Type

Observational

Enrollment (Estimated)

40

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Probability Sample

Study Population

This study primarily utilizes ultrasound multimodal imaging to observe the changes in multiple parameter indicators before and after the treatment of nerve hydrodissection combined with transverse carpal ligament release in patients clinically diagnosed with mild to moderate Carpal Tunnel Syndrome.

Description

Inclusion Criteria:

  1. Age between 18 and 70 years;
  2. Presence of sensory abnormalities and motor dysfunction in the median nerve distribution area;
  3. Positive Tinel's sign or Phalen's test;
  4. Neurophysiological examination consistent with mild to moderate Carpal Tunnel Syndrome.-

Exclusion Criteria:

  1. Severe Carpal Tunnel Syndrome;
  2. Concurrent rheumatic, metabolic, systemic, or other systemic diseases;
  3. Concurrent cervical spondylosis or other peripheral neuropathies;
  4. Wrist joint trauma, surgery, space-occupying lesions, or nerve itself with space-occupying lesions;
  5. Concurrent malignant tumors or severe cardiopulmonary diseases;
  6. History of previous wrist surgery or injections;
  7. Pregnancy;
  8. Allergy to corticosteroids or local anesthetics.-

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Boston Carpal Tunnel Syndrome Questionnaire ,BCTQ
Time Frame: 1,3,6,12 months
The Boston Carpal Tunnel Score is a patient-reported questionnaire that examines symptom severity and overall functional status of patients with carpal tunnel syndrome. The Symptom Severity Scale (SSS) with 11 questions is scored on a Likert scale of 1-5 and the Functional Status Scale (FSS) with 8 questions is scored from 1-5 with 1 as no difficulty and 5 as difficult.The higher scores mean a worse outcome.
1,3,6,12 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
the patient's sensory nerve conduction velocity (SNCV)
Time Frame: 3,6,12months
SNCV in m/s
3,6,12months
the patient's distal motor latency (DML).
Time Frame: 3,6,12months
DML in ms
3,6,12months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

February 1, 2025

Primary Completion (Estimated)

December 1, 2025

Study Completion (Estimated)

December 1, 2028

Study Registration Dates

First Submitted

December 22, 2024

First Submitted That Met QC Criteria

January 4, 2025

First Posted (Actual)

March 25, 2025

Study Record Updates

Last Update Posted (Actual)

March 25, 2025

Last Update Submitted That Met QC Criteria

January 4, 2025

Last Verified

January 1, 2025

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Carpal Tunnel Syndrome (CTS)

Clinical Trials on Ultrasound-guided nerve hydrodissection treatment

Subscribe